1Diwakaran HH, Befeler AS, Britton RS, Brunt EM, Bacon BR.Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J Hepatol 2002;36:687-691.
2Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004;53:744-749.
3Al-Quaiz MN, Madani TA, Karawi MA. The natural history of hepatitis C virus infection. Saudi Med J 2003;24(Suppl 2):S67-70.
4Machida K, Cheng KT, Sung VM, Lee KJ, Levine AM, Lai MM.Hepatitis C virus infection activates the immunologic (type Ⅱ)isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 2004;78:8835-8843.
5Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K,Kimura S, Moriya K, Koike K. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-848.
6Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J,O'Rahilly S, Shore S, Tom BD, Alexander GJ. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;30:1059-1063.
7Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG,Gasbarrini G. HCV infection and extrahepatic manifestations.Hepatogastroenterology 2003;50:1149-1154.
8Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L,Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani ES, Dural J. Immunological disorders in C virus chronic active hepatitis:a prospective case-control study. Hepatology 1994;9:841-848.
